Research Disclaimer
This article reviews published scientific literature for educational purposes only. All compounds referenced are sold by Blank Peptides exclusively for in-vitro research and laboratory use. Nothing in this article constitutes medical advice, a treatment recommendation, or an endorsement of human use.
Growth hormone attracts serious research and a lot of gym folklore at the same time. GH secretagogues, peptides that trigger the body to release its own growth hormone, are more interesting than direct hormone replacement because they work with the body’s existing signaling. Ipamorelin and CJC-1295 are the most researched duo in this space.
Why Secretagogues Over Exogenous GH
Growth hormone is released by the anterior pituitary in response to two main signals:
- GHRH (growth hormone-releasing hormone): from the hypothalamus, tells the pituitary “release GH now”
- Somatostatin, also from the hypothalamus, tells it “stop releasing GH”
Exogenous GH bypasses this system entirely. It floods the bloodstream, suppresses natural release, and flattens the pulsatile pattern. Secretagogues push on the system from inside it. GH still comes out of your own pituitary, the pulsatile pattern survives, and the feedback loops keep running.
Ipamorelin: The Selective Ghrelin Mimetic
Ipamorelin is a pentapeptide that binds the ghrelin receptor (GHS-R1a). What distinguishes it from other GHRPs is selectivity:
- GH release: strong stimulation through physiologic ghrelin pathways
- Cortisol shows no meaningful alteration, where most GHRPs increase it
- Prolactin, no meaningful alteration
- Aldosterone, no meaningful alteration
- Appetite increase: expected from ghrelin receptor activation, useful or unwelcome depending on the protocol
CJC-1295: The Extended GHRH Analog
CJC-1295 is a synthetic GHRH analog that mimics the hypothalamic signal telling the pituitary to release GH, with a much longer duration:
- Natural GHRH: half-life of minutes, cleared quickly by normal metabolism
- CJC-1295 with DAC has a half-life of roughly 6-8 days via albumin binding, giving sustained, consistent GH stimulation
- CJC-1295 without DAC clears in about 30 minutes, which buys precise timing at the cost of more frequent dosing
The Stack: Why They’re Used Together
Ipamorelin and CJC-1295 work on different parts of the same system:
- Ipamorelin: triggers the GH pulse via the ghrelin receptor (the “go” signal)
- CJC-1295: amplifies GH release via the GHRH receptor (the “amplifier” signal)
Research Applications
Body Composition
- Increased lean mass: GH drives protein synthesis rates
- Fat mass falls with enhanced lipolysis (fat breakdown)
- Metabolic markers improve, including glucose metabolism and substrate use
Recovery and Performance
- Tissue repair: GH supports protein synthesis and structural recovery
- Glycogen repletion runs faster after training
- Muscle preservation: reduced breakdown during caloric deficit or stress
Metabolic and Anti-Aging
- Blood sugar regulation: GH affects insulin sensitivity and glucose handling
- Age-related GH decline, where secretagogues address somatopause through a physiologic mechanism
- Bone density support, through GH’s role in bone mineral maintenance
Safety Profile
Part of the appeal of secretagogues is safety, which follows from working with the body’s signaling rather than replacing hormones:
- Cleaner than exogenous GH: joint pain, carpal tunnel, and insulin resistance risks are substantially reduced
- Ipamorelin side effects: increased appetite from ghrelin activation, mild and expected
- CJC-1295 side effects: occasional transient flushing
- Long-term data limited: most studies are short-term, so extended use carries real uncertainty
Browse These Compounds
Ipamorelin/CJC-1295 No DACIpamorelinCJC-1295 No DACCJC-1295 DACSermorelin